Skip to main content

Iron Management

  • Chapter
  • First Online:
  • 885 Accesses

Abstract

For the last two decades, iron deficiency has been categorized as either absolute or functional. Absolute iron deficiency implies that there is a deficiency in total body iron stores, such that there are inadequate levels of iron to supply the bone marrow. The two types of iron deficiency are often compared to a bank account. Absolute iron deficiency implies that there is simply not enough money in the bank to be able to make a withdrawal. Functional iron deficiency is a condition in which there are normal or even increased levels of total body iron stores, but there is a failure to mobilize this iron for use by the bone marrow for erythropoiesis. To continue the bank account analogy, functional iron deficiency is illustrated by a condition in which there is an ample amount of money in a savings account, but it cannot be withdrawn on demand.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   49.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Macdougall IC. Monitoring of iron status and iron supplementation in patients treated with erythropoietin. Curr Opin Nephrol Hypertens. 1994;3:620-625.

    Google Scholar 

  2. Babitt JL, Lin HY. Molecular mechanisms of hepcidin regulation: implications for the anemia of CKD. Am J Kidney Dis. 2010;55:726-741.

    Google Scholar 

  3. Tessitore N, Solero GP, Lippi G, et al. The role of iron status markers in predicting response to intravenous iron in haemodialysis patients on maintenance erythropoietin. Nephrol Dial Transplant. 2001;16:1416-1423.

    Google Scholar 

  4. Beguin Y. Soluble transferrin receptor for the evaluation of erythropoiesis and iron status. Clin Chim Acta. 2003;329:9-22.

    Google Scholar 

  5. Tessitore N, Girelli D, Campostrini N, et al. Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents. Nephrol Dial Transplant. 2010;25:3996-4002.

    Google Scholar 

  6. Macdougall IC. Strategies for iron supplementation: oral versus intravenous. Kidney Int Suppl. 1999;69:S61-S66.

    Google Scholar 

  7. Charytan C, Qunibi W, Bailie GR; Venofer Clinical Studies Group. Comparison of intravenous iron sucrose to oral iron in the treatment of anemic patients with chronic kidney disease not on dialysis. Nephron Clin Pract. 2005;100:c55-c62.

    Google Scholar 

  8. Bailie GR, Horl WH, Verhoef JJ. Differences in spontaneously reported hypersensitivity and serious adverse events for intravenous iron preparations: comparison of Europe and North America. Arzneimittelforschung. 2011;61:267-275.

    Google Scholar 

  9. Chandler G, Harchowal J, Macdougall IC. Intravenous iron sucrose: establishing a safe dose. Am J Kidney Dis. 2001;38:988-991.

    Google Scholar 

  10. Ferinject [package insert]. Neuilly-sur-Seine, France: Vifor Pharma; 2011.

    Google Scholar 

  11. Monofer [package insert]. Holbaek, Denmark: Pharmacosmos; 2009.

    Google Scholar 

  12. Feraheme [package insert]. Lexington, MA: AMAG Pharmaceuticals; 2011.

    Google Scholar 

  13. Toblli JE, Cao G, Oliveri L, Angerosa M. Assessment of the extent of oxidative stress induced by intravenous ferumoxytol, ferric carboxymaltose, iron sucrose and iron dextran in a nonclinical model. Arzneimittelforschung. 2011;61:399-410.

    Google Scholar 

  14. Venofer [package insert]. Shirley, NY: American Regent; 2011.

    Google Scholar 

  15. Toblli JE, Cao G, Oliveri L, Angerosa M. Comparison of oxidative stress and inflammation induced by different intravenous iron sucrose similar preparations in a rat model. Inflamm Allergy Drug Targets. 2012;11:66-78.

    Google Scholar 

  16. Locatelli F, Aljama P, Barany P, et al. Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant. 2004;19(suppl 2):ii1-47.

    Google Scholar 

  17. Bailie GR, Clark JA, Lane CE, et al. Hypersensitivity reactions and deaths associated with intravenous iron preparations. Nephrol Dial Transplant. 2005;20:1443-1449.

    Google Scholar 

  18. National Kidney Foundation. KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Int Suppl. 2012;2:v-335.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Healthcare

About this chapter

Cite this chapter

Macdougall, I.C. (2013). Iron Management. In: Pocket Reference to Renal Anemia. Springer Healthcare, Tarporley. https://doi.org/10.1007/978-1-907673-48-1_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-907673-48-1_5

  • Published:

  • Publisher Name: Springer Healthcare, Tarporley

  • Print ISBN: 978-1-908517-74-6

  • Online ISBN: 978-1-907673-48-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics